Dongyao Pharmaceutical-B (01875) announced that Qiu Yumin has resigned as the company's non-executive director, chairman of the remuneration committee, and a member of the Audit and Related Party Transaction Review Committee and Strategy and ESG Committee due to the need to concentrate more energy on handling other businesses, all effective from August 12, 2023. Mr. Qiu will also resign as a director of Dongyao Pharmaceutical Co., Ltd. (Suzhou Dongyao), a wholly-owned subsidiary of the company, in due course.
Furthermore, Liu Weidong has been appointed as the company's non-executive director, chairman of the remuneration committee, and a member of the Audit and Related Party Transactions Review Committee and Strategy and ESG Committee, all effective from August 12, 2023. Dr. Liu Weidong will also be appointed as a director of Suzhou Dongyao in due course.